Imaging study explores tumor microperfusion in lipomatous soft tissue tumors, indicating contrast-enhanced ultrasound may distinguish benign lipomas from liposarcomas.
Lipomatous soft tissue tumors (STT), ranging from benign lipomas to malignant liposarcomas, require accurate differentiation for timely treatment. Complementary to MRI, Contrast-enhanced ultrasound (CEUS) is emerging as a promising tool, providing insight into tumor microperfusion in real-time. This study aims to explore the potential of preoperative CEUS in differentiating benign lipomatous tumors from malignant liposarcoma subtypes.
No takes yet. Share an insight, caveat, or question.
Mick et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: